Ischemia-modified albumin level in type 2 diabetes mellitus - Preliminary report

Disease Markers

Volumn 24, Issue 6, 2008, Pages 311-317

  Piwowar, Agnieszka ^a   Knapik Kordecka, Maria ^a   Warwas, Maria ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

COBALT; FRUCTOSAMINE; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ISCHEMIA MODIFIED ALBUMIN; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ANALYTICAL PARAMETERS; ARTICLE; BINDING ASSAY; BLOOD PRESSURE; CHOLESTEROL BLOOD LEVEL; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETIC ANGIOPATHY; DIABETIC PATIENT; DISEASE ASSOCIATION; DYSLIPIDEMIA; FEMALE; FRUCTOSAMINE BLOOD LEVEL; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERTENSION; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MICROANGIOPATHY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SPECTROPHOTOMETRY; TRIACYLGLYCEROL BLOOD LEVEL; VASCULAR DISEASE;

EID: 49149097137     PISSN: 02780240     EISSN: None     Source Type: Journal    
DOI: 10.1155/2008/784313     Document Type: Article

References (32)

1. H. Abboud and J. Labreuche, Ischemia-modified albumin in acute stroke, Cerebrovasc Dis 23 (2007), 216-220.
2. F.S. Apple and H.E. Quist, Release characteristics of cardiac biomarkers and ischemia-modified albumin as measured by the albumin cobalt-binding test after a marathon race, Clin Chem 48 (2002), 1097-1100.
3. F.S. Apple and A.H.B. Wu, Future biomarkers for detection of ischemia and risk stratification in acute coronary syndrome, Clin Chem 51 (2005), 810-824.
4. D. Bar-Or and E.L. Lau, A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia - a preliminary report, J Emerg Med 19 (2000), 311-315.
5. 2+ binding amino-acid residues of the N-terminus of human albumin. As insight into the mechanism of a new assay for myocardial ischemia, Eur J Biochem 268 (2001), 42-47.
6. D. Bonnefont-Rousselot, Glucose and reactive oxygen species, Curr Op Clin Nut Metab Care 5 (2002), 561-568.
7. D. Borderie and Y. Allanore, High ischemia-modified albumin concentration reflects oxidative stress but not myocardial involvement in systemic sclerosis, Clin Chem 50 (2004), 2190-2193.
8. E. Bourdon and N. Loreau, Glucose and free radicals impair the antioxidant properties of serum albumin, FASEB J 12 (1999), 233-244.
9. A. Ceriello, Acute hyperglycaemia: a "new" risk factor during myocardial infarction, Eur Heart J 26 (2005), 328-331.
10. A. Ceriello and E. Motz, Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited, Artheroscler Thromb Vasc Biol 24 (2004), 816-823.
11. B. Chan and N. Dodsworth, Site-specific N-terminal autodegradation of human serum albumin, Eur J Biochem 227 (1995), 524-528.
12. R.H. Christenson and S.H. Duh, Characteristics of an albumin cobalt binding test for assessment of acute coronary syndrome patients: a multicenter study, Clin Chem 47 (2001), 464-470.
13. S. Gidenne and F. Ceppa, Analytical performance of the Albumin Cobalt Binding (ACB) test on the Cobas MIRA Plus analyzer, Clin Chem Lab Med 42 (2004), 455-461.
14. M. Kalousová and J. Śkrha, Advanced glycation end-products and advanced oxidation protein products in patients with diabetes mellitus, Physiol Res 51 (2002), 597-604.
15. M. Kalousová and A. Zak, Advanced glycation and oxidation products in patients with atherosclerosis, Cas Lek Cesk 144 (2005), 385-389.
16. J.P. Kuyvenhoven and A.E. Meinders, Oxidative stress and diabetes mellitus pathogenesis of long-term complications, Eur J Intern Med 10 (1999), 9-19.
17. S.R. Laver and A. Padkin, Does hyperglycaemia precede the clinical onset of myocardial ischaemia? Resuscitation 66 (2005), 237-239.
18. G. Lippi and M. Montagnana, Albumin cobalt binding and ischemia modified albumin generation: an endogenous response to ischemia? Int J Cardiol 108 (2006), 410-411.
19. G. Lippi and G.L. Salvagno, Influence of physical exercise and relationship with biochemical variables of NT-pro-brain natriuretic peptide and ischemia modified albumin, Clin Chim Acta 367 (2006), 175-180.
20. M. Montagnana and G. Lippi, Ischemia-modified albumin and NT-prohormone-brain natriuretic peptide in peripheral arterial disease, Clin Chem Lab Med 44 (2006), 207-212.
21. M. Montagnana and G. Lippi, Evaluation of cardiac laboratory markers in patients with systemic sclerosis, Clin Biochem 39 (2006), 913-917.
22. M. Montagnana and G. Lippi, Evaluation of cardiac involvement following major orthopedic surgery, Clin Chem Lab Med 44 (2006), 1340-1346.
23. A. Piwowar and M. Knapik-Kordecka, AOPP and its relations with selected markers of oxidative/antioxidative system in type 2 diabetes mellitus, Diabetes Res Clin Pract 77 (2007), 188-192.
24. M.A. Rafaai and R.W. Wright, Ischemia-modified albumin increases after skeletal muscle ischemia during arthroscopic knee surgery, Clin Chim Acta 366 (2006), 264-268.
25. R.P. Robertson and J. Harmon, β-Cell glucose toxicity, lipotoxicity, and chronic oxidative stress in type 2 diabetes, Diabetes 53(Suppl 1) (2004), S119-S124.
26. D. Roy and J. Quiles, Ischemia-modified albumin concentrations in patients with peripheral vascular disease and exercise-induced skeletal muscle ischemia, Clin Chem 50 (2004), 1656-1660.
27. D. Roy and J. Quiles, Role of reactive oxygen species on the formation of the novel diagnostic marker ischaemia modified albumin, Heart 92 (2006), 113-114.
28. M. Senes ans N. Kazan, Oxidative and nitrosative stress in acute ischaemic stroke, Ann Clin Biochem 44 (2007), 43-47.
29. M. Skvarilowa and A. Bulava, Increased level of advanced oxidation products (AOPP) as a marker of oxidative stress in patients with acute coronary syndrome, Biomed Papers 149 (2005), 83-87.
30. E.R. Stadtman and B.S. Berlett, Reactive oxygen-mediated protein oxidation in aging and disease, Chem Res Toxicol 10 (1997), 485-494.
31. M. Troxler M. and D. Thompson, Ischaemic skeletal muscle increases serum ischaemia modified albumin, Eur J Vasc Endovasc Surg 31 (2006), 164-169.
32. Zapico-Muñiz and M. Santaló-Bel, Ischemia-modified albumin during skeletal muscle ischemia, Clin Chem 50 (2004), 1063-1065.